Alterity Therapeutics Ltd (ATH) - Net Assets

Latest as of December 2025: AU$54.27 Million AUD ≈ $38.40 Million USD

Based on the latest financial reports, Alterity Therapeutics Ltd (ATH) has net assets worth AU$54.27 Million AUD (≈ $38.40 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$56.92 Million ≈ $40.27 Million USD) and total liabilities (AU$2.65 Million ≈ $1.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Alterity Therapeutics Ltd (ATH) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$54.27 Million
% of Total Assets	95.34%
Annual Growth Rate	N/A
5-Year Change	39.16%
10-Year Change	35.18%
Growth Volatility	80.58

Alterity Therapeutics Ltd - Net Assets Trend (1998–2025)

This chart illustrates how Alterity Therapeutics Ltd's net assets have evolved over time, based on quarterly financial data. See ATH cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Alterity Therapeutics Ltd (1998–2025)

The table below shows the annual net assets of Alterity Therapeutics Ltd from 1998 to 2025. For live valuation and market cap data, see Alterity Therapeutics Ltd market cap and net worth.

Year	Net Assets	Change
2025-06-30	AU$42.40 Million ≈ $30.00 Million	+207.31%
2024-06-30	AU$13.80 Million ≈ $9.76 Million	-39.52%
2023-06-30	AU$22.81 Million ≈ $16.14 Million	-35.68%
2022-06-30	AU$35.47 Million ≈ $25.10 Million	+16.40%
2021-06-30	AU$30.47 Million ≈ $21.56 Million	+188.88%
2020-06-30	AU$10.55 Million ≈ $7.46 Million	-36.28%
2019-06-30	AU$16.55 Million ≈ $11.71 Million	+2.95%
2018-06-30	AU$16.08 Million ≈ $11.38 Million	-32.12%
2017-06-30	AU$23.69 Million ≈ $16.76 Million	-24.48%
2016-06-30	AU$31.37 Million ≈ $22.19 Million	-19.80%
2015-06-30	AU$39.11 Million ≈ $27.68 Million	+3.79%
2014-06-30	AU$37.69 Million ≈ $26.67 Million	+169.67%
2013-06-30	AU$13.97 Million ≈ $9.89 Million	+148.51%
2012-06-30	AU$5.62 Million ≈ $3.98 Million	-18.87%
2011-06-30	AU$6.93 Million ≈ $4.90 Million	+32.55%
2010-06-30	AU$5.23 Million ≈ $3.70 Million	+39.46%
2009-06-30	AU$3.75 Million ≈ $2.65 Million	-62.08%
2008-06-30	AU$9.89 Million ≈ $7.00 Million	+76.22%
2007-06-30	AU$5.61 Million ≈ $3.97 Million	-35.76%
2006-06-30	AU$8.73 Million ≈ $6.18 Million	-55.24%
2005-06-30	AU$19.51 Million ≈ $13.81 Million	-49.27%
2004-06-30	AU$38.47 Million ≈ $27.22 Million	+143.82%
2003-06-30	AU$15.78 Million ≈ $11.16 Million	-5.40%
2002-06-30	AU$16.68 Million ≈ $11.80 Million	-22.04%
2001-06-30	AU$21.39 Million ≈ $15.14 Million	+3.20%
2000-06-30	AU$20.73 Million ≈ $14.67 Million	+25796.43%
1999-06-30	AU$-80.67K ≈ $-57.08K	-11940.30%
1998-06-30	AU$-670.00 ≈ $-474.07	--

Equity Component Analysis

This analysis shows how different components contribute to Alterity Therapeutics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 22588868000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$262.95 Million	620.12%
Other Comprehensive Income	AU$5.34 Million	12.60%
Total Equity	AU$42.40 Million	100.00%

Alterity Therapeutics Ltd Competitors by Market Cap

The table below lists competitors of Alterity Therapeutics Ltd ranked by their market capitalization.

Company	Market Cap
Woongjin Co Ltd KO:016880	$108.76 Million
Sastasundar Ventures Limited NSE:SASTASUNDR	$108.78 Million
Tamil Nadu Newsprint & Papers Limited NSE:TNPL	$108.82 Million
Coya Therapeutics, Inc. Common Stock NASDAQ:COYA	$108.84 Million
Riber S.A PA:ALRIB	$108.73 Million
Endava plc F:2Y5	$108.70 Million
DongKook Pharmaceutical Co. Ltd KQ:086450	$108.65 Million
Uniquest KO:077500	$108.61 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Alterity Therapeutics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 13,798,057 to 42,403,086, a change of 28,605,029 (207.3%).
Net loss of 12,147,828 reduced equity.
Share repurchases of 42,570,650 reduced equity.
New share issuances of 42,570,645 increased equity.
Other comprehensive income increased equity by 536,101.
Other factors increased equity by 40,216,761.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-12.15 Million	-28.65%
Share Repurchases	AU$42.57 Million	-100.4%
Share Issuances	AU$42.57 Million	+100.4%
Other Comprehensive Income	AU$536.10K	+1.26%
Other Changes	AU$40.22 Million	+94.84%
Total Change	AU$-	207.31%

Book Value vs Market Value Analysis

This analysis compares Alterity Therapeutics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 90.52x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1998-06-30	AU$0.00	AU$0.60	x
1999-06-30	AU$0.00	AU$0.60	x
2000-06-30	AU$0.63	AU$0.60	x
2001-06-30	AU$0.41	AU$0.60	x
2002-06-30	AU$0.31	AU$0.60	x
2003-06-30	AU$0.27	AU$0.60	x
2004-06-30	AU$0.52	AU$0.60	x
2005-06-30	AU$0.16	AU$0.60	x
2006-06-30	AU$0.07	AU$0.60	x
2007-06-30	AU$0.04	AU$0.60	x
2008-06-30	AU$0.06	AU$0.60	x
2009-06-30	AU$0.02	AU$0.60	x
2010-06-30	AU$0.02	AU$0.60	x
2011-06-30	AU$0.03	AU$0.60	x
2012-06-30	AU$0.02	AU$0.60	x
2013-06-30	AU$0.04	AU$0.60	x
2014-06-30	AU$0.09	AU$0.60	x
2015-06-30	AU$0.08	AU$0.60	x
2016-06-30	AU$0.06	AU$0.60	x
2017-06-30	AU$0.04	AU$0.60	x
2018-06-30	AU$0.03	AU$0.60	x
2019-06-30	AU$0.03	AU$0.60	x
2020-06-30	AU$0.01	AU$0.60	x
2021-06-30	AU$0.02	AU$0.60	x
2022-06-30	AU$0.01	AU$0.60	x
2023-06-30	AU$0.01	AU$0.60	x
2024-06-30	AU$0.00	AU$0.60	x
2025-06-30	AU$0.01	AU$0.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Alterity Therapeutics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -28.65%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -223.35%
• Asset Turnover: 0.12x
• Equity Multiplier: 1.09x
Recent ROE (-28.65%) is above the historical average (-67.40%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1998	0.00%	0.00%	0.00x	0.00x	AU$-623.00
1999	0.00%	0.00%	0.00x	0.00x	AU$-71.93K
2000	-6.40%	-1684.00%	0.00x	1.01x	AU$-3.40 Million
2001	-19.35%	-801.84%	0.02x	1.04x	AU$-6.28 Million
2002	-32.69%	-686.23%	0.05x	1.05x	AU$-7.12 Million
2003	-28.97%	-252.40%	0.11x	1.04x	AU$-6.15 Million
2004	-25.54%	-425.88%	0.06x	1.07x	AU$-13.67 Million
2005	-127.63%	-942.61%	0.12x	1.14x	AU$-26.86 Million
2006	-134.25%	-1537.92%	0.07x	1.19x	AU$-12.60 Million
2007	-198.54%	-2197.05%	0.07x	1.38x	AU$-11.70 Million
2008	-137.44%	-2762.17%	0.04x	1.19x	AU$-14.58 Million
2009	-200.62%	-1756.87%	0.09x	1.23x	AU$-7.90 Million
2010	-93.83%	-2282.20%	0.03x	1.30x	AU$-5.43 Million
2011	-92.79%	-4118.99%	0.02x	1.30x	AU$-7.12 Million
2012	-93.17%	-2806.90%	0.03x	1.31x	AU$-5.80 Million
2013	-55.72%	-5161.66%	0.01x	1.22x	AU$-9.18 Million
2014	-35.37%	-3664.14%	0.01x	1.10x	AU$-17.10 Million
2015	-15.05%	-3327.87%	0.00x	1.07x	AU$-9.80 Million
2016	-24.64%	-5418.28%	0.00x	1.08x	AU$-10.87 Million
2017	-31.84%	-5696.60%	0.01x	1.07x	AU$-9.91 Million
2018	-51.40%	-4108.75%	0.01x	1.16x	AU$-9.87 Million
2019	-72.26%	-11020.84%	0.01x	1.20x	AU$-13.62 Million
2020	-95.37%	-58759.84%	0.00x	1.26x	AU$-11.11 Million
2021	-50.24%	-352.78%	0.13x	1.10x	AU$-18.36 Million
2022	-36.22%	-250.75%	0.12x	1.17x	AU$-16.39 Million
2023	-60.52%	-352.54%	0.14x	1.20x	AU$-16.09 Million
2024	-138.60%	-475.79%	0.21x	1.39x	AU$-20.50 Million
2025	-28.65%	-223.35%	0.12x	1.09x	AU$-16.39 Million

Industry Comparison

This section compares Alterity Therapeutics Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $5,560,880
Average return on equity (ROE) among peers: -153.47%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Alterity Therapeutics Ltd (ATH)	AU$54.27 Million	0.00%	0.05x	$108.75 Million
Adalta Ltd (1AD)	$7.49 Million	-79.00%	0.24x	$5.41 Million
Algorae Pharmaceuticals Ltd (1AI)	$1.80 Million	-379.70%	1.37x	$14.31 Million
ACRUX Ltd (ACR)	$3.28 Million	-177.05%	1.74x	$4.36 Million
Actinogen Medical Ltd (ACW)	$9.37 Million	-34.06%	0.09x	$78.71 Million
Argenica Therapeutics Ltd (AGN)	$8.31 Million	-49.24%	0.09x	$10.00 Million
Arovella Therapeutics Ltd (ALA)	$10.51 Million	-87.53%	0.53x	$60.73 Million
Anatara Lifesciences Ltd (ANR)	$535.97K	-364.70%	1.14x	$1.92 Million
Amplia Therapeutics Ltd (ATX)	$4.87 Million	-107.62%	0.09x	$41.77 Million
Avecho Biotechnology Ltd (AVE)	$3.90 Million	-102.34%	0.23x	$40.65 Million

About Alterity Therapeutics Ltd

AU:ATH Australia Biotechnology

Market Cap

$4.62 Billion

AU$6.53 Billion AUD

Market Cap Rank

#18933 Global

#605 in Australia

Share Price

AU$0.60

Change (1 day)

+2.56%

52-Week Range

AU$0.01 - AU$0.60

All Time High

AU$0.60